SNAP47 and metabolic dysfunction-associated steatotic liver disease: Furthermore, sVAP-1 is significantly elevated in patients with nonalcoholic fatty liver disease (NAFLD), suggesting its potential role as a pathogenic link between NAFLD and CVD (32).